⌘K

Login Start Free

Home/Filings/4/0001209191-22-007328

4//SEC Filing

Friedman Bart 4

Accession 0001209191-22-007328

CIK 0001636651other

View on SEC.gov Company Profile

Filed

Feb 3, 7:00 PM ET

Accepted

Feb 4, 8:50 PM ET

Size

5.3 KB

Accession

0001209191-22-007328

Insider Transaction Report

Form 4

Period: 2022-02-03

Ovid Therapeutics Inc.OVID

Director

Transactions

Award
Stock Option (Right to Buy)
2022-02-03+15,000→ 15,000 total
Exercise: $2.72Exp: 2032-02-02→ Common Stock (15,000 underlying)

Footnotes (1)

[F1]The option will vest in full on February 3, 2023 subject to the Reporting Person's continuous service through such vesting date.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Ovid Therapeutics Inc.

CIK 0001636651

Entity typeother

Related Parties

1

filerCIK 0001368324

Filing Metadata

Form type: 4
Filed: Feb 3, 7:00 PM ET
Accepted: Feb 4, 8:50 PM ET
Size: 5.3 KB

View on SEC.gov